Draper, United States
Glendor, Inc, founded in 2017 and headquartered in the United States, operates at the intersection of Health Care and Information Technology. With a mission encapsulated in its slogan, "Our mission is to protect patients' privacy while empowering medical data sharing," the company offers a robust solution for the de-identification of Protected Health Information (PHI).
Glendor addresses significant challenges faced by hospitals, such as inefficient manual processes and the risks involved with third-party data handling. Their standout product, the Glendor PHI Sanitizer, promises a fully automatic, easy-to-integrate solution that processes data on-premises, safeguarding sensitive patient data against external exposure.
With a client base that includes prominent sectors like hospitals, the NIH, and Big Pharma, Glendor offers a scalable, multi-modal approach to data de-identification that aligns perfectly with the requirements of modern medical data handling. Despite its strategic offerings and rich industry presence, the company has not disclosed recent investment activity, presenting an intriguing opportunity for investors seeking to enter a niche, yet crucial, market segment.
